Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous PSA measurement, Clinical Stage and biopsy Gleason score

OBJECTIVE: Current 2007 Partin Tables restricts the application of total PSA (tPSA) as a non-continuous biomarker by creating “groups” for the risk stratification with tPSA value of 0-2.5, 2.6-4.0, 4.1-6.0, 6.1-10.0, and >10.0 ng/ml. Hence we developed a “2010 Partin Nomogram” with tPSA as a cont...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huang, Ying, Isharwal, Sumit, Haese, Alexander, Chun, Felix K.H., Makarov, Danil V., Feng, Ziding, Han, Misop, Humphreys, Elizabeth, Epstein, Jonathan I., Partin, Alan W., Veltri, Robert W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082635/
https://ncbi.nlm.nih.gov/pubmed/20875091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2010.09692.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares